Literature DB >> 12634922

Recruitment of renal dopamine 1 receptors requires an intact microtubulin network.

Maria Sol Kruse1, Shinsuke Adachi, Lena Scott, Ulla Holtbäck, Paul Greengard, Anita Aperia, Hjalmar Brismar.   

Abstract

Renal dopamine1 receptor (D1R) can be recruited from intracellular compartments to the plasma membrane by D1R agonists and endogenous dopamine. This study examines the role of the cytoskeleton for renal D1R recruitment. The studies were performed in LLCPK-1 cells that have the capacity to form dopamine from L-dopa. In approximately 50% of the cells treated with L-dopa the D1R was found to be translocated from intracellular compartments towards the plasma membrane. Disruption of the microtubulin network by nocodazole significantly prevented translocation. In contrast, depolymerization of actin had no effect. In control cells D1R colocalized with NBD-C(6)-ceramide, a trans-Golgi fluorescent marker. This colocalization was disrupted in L-dopa-treated cells. Tetanus toxin, an inhibitor of exocytosis, prevented L-dopa-induced receptor recruitment. L-Dopa treatment resulted in activation of protein kinase C (PKC). To test the functional effect of D1R recruitment, the capacity of D1R agonists to activate PKC was studied. Activation of D1R significantly translocated PKC-alpha from intracellular compartments to the plasma membrane. Disruption of microtubules abolished D1R-mediated - but not phorbol-ester-mediated - translocation of PKC. We conclude that renal D1R recruitment requires an intact microtubulin network and occurs via Golgi-derived vesicles. These newly recruited receptors couple to the PKC signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12634922     DOI: 10.1007/s00424-002-0899-5

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  11 in total

Review 1.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

2.  Mechanisms of dopamine D(1) and angiotensin type 2 receptor interaction in natriuresis.

Authors:  Shetal H Padia; Brandon A Kemp; Nancy L Howell; Susanna R Keller; John J Gildea; Robert M Carey
Journal:  Hypertension       Date:  2011-12-27       Impact factor: 10.190

3.  The role of endocytosis in renal dopamine D1 receptor signaling.

Authors:  Hjalmar Brismar; Xiang Hua; Shinsuke Adachi; Ulla Holtbäck
Journal:  Pflugers Arch       Date:  2005-10-11       Impact factor: 3.657

4.  The Dopamine D1 Receptor and Angiotensin II Type-2 Receptor are Required for Inhibition of Sodium Transport Through a Protein Phosphatase 2A Pathway.

Authors:  John J Gildea; Peng Xu; Brandon A Kemp; Robert M Carey; Pedro A Jose; Robin A Felder
Journal:  Hypertension       Date:  2019-06       Impact factor: 10.190

5.  Dopamine and angiotensin type 2 receptors cooperatively inhibit sodium transport in human renal proximal tubule cells.

Authors:  John J Gildea; Xiaoli Wang; Neema Shah; Hanh Tran; Michael Spinosa; Robert Van Sciver; Midori Sasaki; Junichi Yatabe; Robert M Carey; Pedro A Jose; Robin A Felder
Journal:  Hypertension       Date:  2012-06-18       Impact factor: 10.190

Review 6.  Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation.

Authors:  Pedro A Jose; Patricio Soares-da-Silva; Gilbert M Eisner; Robin A Felder
Journal:  Biochim Biophys Acta       Date:  2010-02-12

7.  Intrarenal angiotensin III infusion induces natriuresis and angiotensin type 2 receptor translocation in Wistar-Kyoto but not in spontaneously hypertensive rats.

Authors:  Shetal H Padia; Brandon A Kemp; Nancy L Howell; John J Gildea; Susanna R Keller; Robert M Carey
Journal:  Hypertension       Date:  2008-12-15       Impact factor: 10.190

Review 8.  Dopamine, kidney, and hypertension: studies in dopamine receptor knockout mice.

Authors:  Xiaoyan Wang; Van Anthony M Villar; Ines Armando; Gilbert M Eisner; Robin A Felder; Pedro A Jose
Journal:  Pediatr Nephrol       Date:  2008-07-10       Impact factor: 3.714

Review 9.  AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function.

Authors:  Shetal H Padia; Robert M Carey
Journal:  Pflugers Arch       Date:  2012-09-05       Impact factor: 3.657

Review 10.  Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice.

Authors:  Chunyu Zeng; Ines Armando; Yingjin Luo; Gilbert M Eisner; Robin A Felder; Pedro A Jose
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-12-14       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.